生物共振，一种治疗轻度和中度抑郁症的替代疗法。,Experimental and Therapeutic Medicine

当前位置： X-MOL 学术 › Exp. Ther. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

生物共振，一种治疗轻度和中度抑郁症的替代疗法。
Experimental and Therapeutic Medicine ( IF 2.4 ) Pub Date : 2022-02-04 , DOI: 10.3892/etm.2022.11190
Daniela Muresan ₁ , Septimiu Voidăzan ₂ , Andreea Salcudean ₃ , Cristina Raluca Bodo ₄ , Iosif Gabos Grecu ₅

Affiliation

抑郁症是一种消极的情绪状态，可能会持续很短或很长一段时间，严重程度不同。本研究的目的是评估生物共振疗法可以改善患者经历的中度和轻度发作的复发性抑郁症的严重程度的方法。生物共振疗法是一种能量治疗方法，它使用使用电极的敏感 Mora Nova 设备处理人体的电磁信息。此外，将这种改善与通过使用选择性5-羟色胺再摄取抑制剂单一疗法获得的改善进行了比较。该研究包括两组患有抑郁症的患者。第一组接受了为期五周的生物共振治疗。第二组接受了新引入或正在进行的选择性5-羟色胺再摄取抑制剂抗抑郁药的药物治疗，作为单一疗法，为期五周。进行了严重程度的结果测量。结果显示，用于评估抑郁症并包含 17 个项目的汉密尔顿量表的得分提高显示，生物共振组 1 的平均值为 3.1 [标准差 (SD)，1.28]，平均值为 2.2 (SD，0.61)为第二组。两个数据系列之间的差异具有统计学意义（ P <0.0001，学生 t 检验）。由于生物共振治疗结果高于选择性5-羟色胺再摄取抑制剂药物治疗结果，可以得出结论，生物共振可以降低患有中度和轻度发作的复发性抑郁症患者的严重程度。此外，与抗抑郁药物组相比，生物共振组的严重程度降低具有统计学意义。

"点击查看英文标题和摘要"

Bioresonance, an alternative therapy for mild and moderate depression.

Depression is a negative emotional state that may persist for short or long periods of time with varying severity. The aim of the present study was to evaluate the method by which bioresonance therapy can improve the severity of recurrent depressive disorder with moderate and mild episodes experienced by patients. Bioresonance therapy is a method of energy treatment that processes the electromagnetic information of the human body using a sensitive Mora Nova device using electrodes. In addition, this improvement was compared with the one obtained by applying monotherapy with selective serotonin reuptake inhibitors. The study included two groups of patients suffering from depression. The first group received bioresonance treatment for five weeks. The second group received either newly introduced or on-going pharmacological treatment with selective serotonin reuptake inhibitor antidepressants, as monotherapy, for five weeks. An outcome measurement of severity was performed. Results revealed that, the score improvement on the Hamilton Scale, used for assessing depression and comprising 17 items, showed a mean of 3.1 [standard deviation (SD), 1.28] for the bioresonance group one and a mean of 2.2 (SD, 0.61) for the second group. The difference between the two data series was statistically significant (P<0.0001, Student's t-test). As the bioresonance therapy outcome was higher than the selective serotonin reuptake inhibitor medication outcome, it can be concluded that bioresonance can reduce the severity of the patients facing recurrent depressive disorder with moderate and mild episodes. Furthermore, the reduction in severity for the bioresonance group compared with the antidepressant medication group was statistically significant.

更新日期：2022-02-04

点击分享查看原文

点击收藏

公开下载

阅读更多本刊新发论文本刊介绍/投稿指南